Canadian Direct-To-OTC Sale Of Nicotine Inhaler Proposed
This article was originally published in The Tan Sheet
Executive Summary
The Canadian Therapeutic Products Programme is soliciting comments on nonprescription availability of nicotine inhalation devices.
You may also be interested in...
J&J/Merck Pepcid Complete Combines H2 Antagonist/Antacid Ingredients
J&J/Merck's Pepcid Complete is the first OTC stomach remedy to combine a fast-acting antacid ingredient with a long-term acid control ingredient, according to the firm. FDA approved NDA 20-958 for Pepcid Complete Oct. 16.
Nicotine Replacement Combination Therapy Urged In PHS Clinical Guidelines
Patients unable to quit smoking using a single type of first-line pharmacotherapy should be encouraged to use a combined treatment consisting of a nicotine patch and another form of nicotine replacement therapy (NRT) such as a gum or nasal spray, according to new clinical practice guidelines released June 27.
McNeil Nicotrol Inhaler Rx test marketing.
McNEIL NICOTROL INHALER Rx TEST MARKETING commenced in February in Houston, Tex. and will begin in March in Baltimore, Md. The hand-held inhaler delivers menthol-flavored nicotine to its user with each draw, mimicking the act of smoking. McNeil Consumer Products expects to launch the prescription smoking cessation product nationwide during the third or fourth quarter. The long test market may be due to the learning curve for inhaler use by consumers.